API SUPPLIERS

API Suppliers

31

US DMFs Filed

23

CEP/COS Certifications

7

JDMFs Filed

0

EU WC

6

Listed Suppliers

9

API REF. PRICE (USD / KG)

37

API Market Place

35

INTERMEDIATES

0

DOSSIERS // FDF

USA (Orange Book)

85

Europe

13

Canada

19

Australia

0

South Africa

4

Uploaded Dossiers

24

GLOBAL SALES (USD Million)

U.S. Medicaid

167.00

Annual Reports

0

FDF Market Place

2

EXCIPIENTS

352

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

12

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

1

News

44

REF STANDARD

EDQM

3

USP

1

JP

0

Other Listed Suppliers

1

SERVICES

1

Full Screen View

Reset Filter

Price Info

Kirby Eades Gale Baker

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Country

Virtual Booth

Digital Content

Naproxen Sodium

PDF Supplier PDF

URL Supplier Web Content

Patent Number

2034096

Strength per Unit

375 mg

Dosage Form

Sustained Release Tablet

Human Or VET

Human

Patent Expiration Date

2011-01-14

Date Granted

2002-03-26

Filing Date

1991-01-14

Brand Name

NAPRELAN

Route of Administration

Oral

ASK
US

Upload
your Marketing & Sales content

Kirby Eades Gale Baker

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Country

Virtual Booth

Digital Content

Naproxen Sodium

PDF Supplier PDF

URL Supplier Web Content

Patent Number

2034096

Strength per Unit

500 mg

Dosage Form

Sustained Release Tablet

Human Or VET

Human

Patent Expiration Date

2011-01-14

Date Granted

2002-03-26

Filing Date

1991-01-14

Brand Name

NAPRELAN

Route of Administration

Oral

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Find Health Canada Patents Information with Patent Number, Filing Date and Patent Expiration Date of Naproxen Sodium on PharmaCompass.com

Naproxen Sodium

Naproxen Sodium

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

31 API Suppliers

23 USDMF

7 CEP/COS

6 EU WC

35 KDMF

13 NDC API

9 Listed Suppliers

DEVELOPMENTS

5 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

DOSSIERs // Finished Dosage Formulations

145 Dossiers

85 FDA Orange Book

13 Europe

19 Canada

4 South Africa

24 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE

TABLET;ORAL - 220MG

TABLET, EXTENDED RELEASE;ORAL - EQ 375MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 750MG BASE

CAPSULE;ORAL - EQ 200MG BASE

TABLET;ORAL - 500MG;EQ 85MG BASE

TABLET;ORAL - 60MG;EQ 10MG BASE

RELATED EXCIPIENT COMPANIES

Suppliers

38 Roquette

33 Kerry

33 BASF

20 Microlex e.U

19 SPI Pharma

17 Corel Pharma Chem

13 Seppic

13 Gangwal Chemicals

12 Gangwal Healthcare

12 Sigachi Industries

12 Nanjing Well Pharmaceutical

11 Actylis

11 Boai NKY Pharmaceuticals Ltd

11 Ideal Cures Pvt Ltd

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

6 Lonza Capsugel

6 DFE Pharma

5 Ingredion Pharma Solutions

4 ACG Worldwide

4 Kima Chemical

4 Pharmatrans-Sanaq

4 Rochem International Inc

4 DKSH

4 Prachin Chemical

4 Ulanqab Kema New Material

4 Vasa Pharmachem

3 The Dow Chemical Company

3 Clariant

3 Evonik

2 Nomisma Healthcare

2 Qualicaps

2 Shijiazhuang Huaxu Pharmaceutical

2 Aeon Procare

2 Seqens

2 Finar

2 Pfanstiehl

2 Jai Radhe Sales

1 Zhejiang Huakang Pharmaceutical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons